Company Overview of Ability Biomedical Corp.
Hans S. Keirstead Ph.D.
President of NeoStem Oncology, Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 5 Board Members in 5 different organizations across 7 different industries.|
See Board Relationships
1055 West Georgia StreetPhone: 604-689-9912
Vancouver, British Columbia V6E 3R5
Board Members Memberships
President, Chief Executive Officer, and Director
University Of British Columbia
University of Cambridge
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|Dominick C. Colangelo Esq.||Chief Executive Officer, President, Treasurer and Director|
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Robin C. Stracey||Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee|
Cesca Therapeutics Inc.
|Marc H. Hedrick M.D.||Chief Executive Officer, President and Director|
Cytori Therapeutics, Inc.
|Martin P. Rosendale||Chief Executive Officer and Director|
Nuo Therapeutics, Inc.
|$467.3K||Compensation as of Fiscal Year 2013.|